Certificate Online

Pharmacoepidemiology and Pharmacovigilance

London School of Hygiene and Tropical Medicine

6 months
4550 GBP/full
4550 GBP/full
Tuition fee
Apply date
Start date


This intensive modular course in pharmacoepidemiology and pharmacovigilance addresses the increasing need for well informed professionals to work in all areas related to the assessment of drug safety and risk-benefit of drug use.


This course is now being offered in a modular format across three Blocks and delivered via online synchronous teaching. Students can either apply for all three Blocks (with or without assessment), or alternatively to any selection of the individual Blocks (without assessment). Students who complete all three Blocks and the assessment within one academic year will be awarded a Professional Certificate (30 credits). All other students will receive a Certificate of Attendance and Continuing Professional Development (CPD) credits.

The global health challenge of maximising drug safety yet maintaining public confidence has become increasingly complex. Pharmaceutical companies are required to employ named members of staff responsible for pharmacovigilance. NGOs need to have confidence that the medicines and products that they provide to communities are both effective and safe. Health authorities grapple with the need to provide quality care whilst containing a burgeoning drug budget. Regulatory authorities must balance the potential benefits of new drugs with varying levels of suspicion of their potential harm. 

The course is organised into the following three Blocks, with the teaching for each Block delivered synchronously online during the following weeks:

  • Block 1 (6 - 9 December 2021): Introduction to Pharmacoepidemiology
  • Block 2 (7 - 10 February 2022): Introduction to Pharmacovigilance
  • Block 3 (4 - 7 April 2022): Intermediate Pharmacoepidemiology & Pharmacovigilance 

Students can sign up for one, two, or three Blocks. Students who would like to be assessed in order to obtain a Professional Certificate (30 credits) must attend all three Blocks in addition to preparing a project (submitted in May) and taking an exam (in June).

Each Block consists of approximately 27 hours of formal teaching and contact time (via online synchronous teaching/group work). The full assessed course leading to a Professional Certificate (three Blocks plus project and exam within one academic year) comprises 300 total hours between December 2021 and June 2022, which are spent as follows: ~80 hours formal teaching and contact time, ~120 hours self-directed study, and ~100 hours project work.

Programme Structure

  • The aim of this well established training programme is to equip students with a basic understanding of the concepts and practice of pharmacoepidemiology and pharmacovigilance. By the end of the programme, students should be able to:

    • demonstrate an understanding of, and critically evaluate, issues surrounding the risks and benefits of drug use in humans including the cause, manifestations and consequences of adverse drug effects (ADEs), the manner of which these are detected and monitored, and the related historic and legal frameworks
    • be familiar with and compare fundamental statistical, economic and epidemiological concepts and methods
    • gain an understanding of, and reflect upon, important pharmacoepidemiological concepts and methods and how these methods can be applied to specific drug issues and pharmaceutical risk management
    • assess and critically analyse the results of pharmacoepidemiological studies (other investigators'), including critical appraisal of the study question, study design, methods and conduct, statistical analyses and interpretation
    The curriculum will provide an introduction to epidemiology, statistics, pharmacoepidemiology and health economics. It will also cover the historical and legal background to pharmacovigilance and pharmacoepidemiology, and pharmacological basis of ADEs, addressing ADE issues at individual and population levels, and the application of pharmacoepidemiological principles and methods to practical drug issues.

Key information


  • Part-time
    • 6 months

Start dates & application deadlines




30 alternative credits


  • Fully structured
  • Proactive tutoring and support
  • Individual work/assignments (with online group discussions), Online group works/assignments

Academic requirements

We are not aware of any academic requirements for this programme.

English requirements

We are not aware of any English requirements for this programme.

Other requirements

General requirements

The course covers aspects of drug development, licensing, surveillance and policy, and is aimed at personnel who are working (or intending to work) on any of these aspects in the following sectors:

  • the pharmaceutical industry
  • NGOs
  • regulatory bodies
  • health services
  • health policy decision-making agencies

Tuition Fee

To alway see correct tuition fees
  • International

    4550 GBP/full
    Tuition Fee
    Based on the tuition of 4550 GBP for the full programme during 6 months.
  • EU/EEA

    4550 GBP/full
    Tuition Fee
    Based on the tuition of 4550 GBP for the full programme during 6 months.

Discounts for LMICs available. 


Studyportals Tip: Students can search online for independent or external scholarships that can help fund their studies. Check the scholarships to see whether you are eligible to apply. Many scholarships are either merit-based or needs-based.

Fresh content

Updated in the last 3 months

Check the official programme website for potential updates.

Our partners

Pharmacoepidemiology and Pharmacovigilance
London School of Hygiene and Tropical Medicine


Go to your profile page to get personalised recommendations!